PVR and neoplasm: In addition, there is a lack of a clinically relevant tumor model, such as patient-derived xenograft (PDX) and humanized mouse models, that would be invaluable for further investigation of the potential of CD155-targeted CAR T-cell therapy to regulate the endogenous immune microenvironment.